-
Something wrong with this record ?
Hemodialysis Use and Practice Patterns: An International Survey Study
H. Htay, AK. Bello, A. Levin, M. Lunney, MA. Osman, F. Ye, GE. Ashuntantang, E. Bellorin-Font, MB. Gharbi, SN. Davison, M. Ghnaimat, P. Harden, V. Jha, K. Kalantar-Zadeh, PG. Kerr, S. Klarenbach, CP. Kovesdy, VA. Luyckx, B. Neuen, D. O'Donoghue,...
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Arteriovenous Shunt, Surgical MeSH
- Kidney Failure, Chronic therapy MeSH
- Renal Dialysis * MeSH
- Health Services Accessibility MeSH
- Patient Reported Outcome Measures MeSH
- Internationality * MeSH
- Quality of Health Care MeSH
- Practice Patterns, Physicians' * MeSH
- Humans MeSH
- Costs and Cost Analysis MeSH
- Nephrology MeSH
- Cost Sharing MeSH
- Cross-Sectional Studies MeSH
- Surveys and Questionnaires MeSH
- Developing Countries MeSH
- Transportation of Patients MeSH
- Health Expenditures MeSH
- Developed Countries MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
RATIONALE & OBJECTIVE: Hemodialysis (HD) is the most common form of kidney replacement therapy. This study aimed to examine the use, availability, accessibility, affordability, and quality of HD care worldwide. STUDY DESIGN: A cross-sectional survey. SETTING & PARTICIPANTS: Stakeholders (clinicians, policy makers, and consumer representatives) in 182 countries were convened by the International Society of Nephrology from July to September 2018. OUTCOMES: Use, availability, accessibility, affordability, and quality of HD care. ANALYTICAL APPROACH: Descriptive statistics. RESULTS: Overall, representatives from 160 (88%) countries participated. Median country-specific use of maintenance HD was 298.4 (IQR, 80.5-599.4) per million population (pmp). Global median HD use among incident patients with kidney failure was 98.0 (IQR, 81.5-140.8) pmp and median number of HD centers was 4.5 (IQR, 1.2-9.9) pmp. Adequate HD services (3-4 hours 3 times weekly) were generally available in 27% of low-income countries. Home HD was generally available in 36% of high-income countries. 32% of countries performed monitoring of patient-reported outcomes; 61%, monitoring of small-solute clearance; 60%, monitoring of bone mineral markers; 51%, monitoring of technique survival; and 60%, monitoring of patient survival. At initiation of maintenance dialysis, only 5% of countries used an arteriovenous access in almost all patients. Vascular access education was suboptimal, funding for vascular access procedures was not uniform, and copayments were greater in countries with lower levels of income. Patients in 23% of the low-income countries had to pay >75% of HD costs compared with patients in only 4% of high-income countries. LIMITATIONS: A cross-sectional survey with possibility of response bias, social desirability bias, and limited data collection preventing in-depth analysis. CONCLUSIONS: In summary, findings reveal substantial variations in global HD use, availability, accessibility, quality, and affordability worldwide, with the lowest use evident in low- and lower-middle-income countries.
Bhumirajanagarindra Kidney Institute Bangkok Thailand
Centre for Kidney Disease Research University of Queensland Brisbane Australia
Department of Community Health Sciences University of Calgary Calgary Alberta Canada
Department of Intensive Care Austin Health Melbourne Australia
Department of Medicine Monash University Clayton Victoria Australia
Department of Medicine The University of Hong Kong Queen Mary Hospital Hong Kong
Department of Medicine University of Calgary Calgary Alberta Canada
Department of Nephrology General University Hospital Charles University Prague Czech Republic
Department of Nephrology Kidney Foundation Hospital and Research Institute Dhaka Bangladesh
Department of Nephrology Monash Medical Centre Monash Health Clayton Victoria Australia
Department of Renal Medicine Singapore General Hospital Singapore
Dialysis Unit CASMU IAMPP Montevideo Uruguay
Division of Nephology and Hypertension Department of Medicine Saint Louis University Saint Louis MO
Division of Nephrology and Hypertension University of Cape Town Cape Town South Africa
Division of Nephrology Bezmialem Vakif University Istanbul Turkey
Division of Nephrology Department of Medicine University of Toronto Toronto Ontario Canada
George Institute for Global Health UNSW New Delhi
Institute of Biomedical Ethics and the History of Medicine University of Zurich Zurich Switzerland
Key Lab of Renal Disease Ministry of Health of China Beijing China
Kidney and Hypertension Research Unit University of Cape Town Cape Town South Africa
Manipal Academy of Higher Education Manipal India
Nephrology Development Clinical Center Tbilisi State Medical University Tbilisi Georgia
Nephrology Division Department of Internal Medicine The Specialty Hospital Amman Jordan
Oxford Kidney Unit Oxford University Hospitals NHS Foundation Trust Oxford United Kingdom
Peking Tsinghua Center for Life Sciences Beijing China
Population Health Sciences University of Bristol Bristol United Kingdom
Renal Division Brigham and Women's Hospital Harvard Medical School Boston MA
Renal Division Department of Medicine Peking University 1st Hospital Beijing China
Renal Unit Southmead Hospital North Bristol NHS Trust Bristol United Kingdom
Salford Royal NHS Foundation Trust Salford
School of Medicine University of Melbourne Melbourne Australia
School of Public Health Imperial College London United Kingdom
Sorbonne Université Paris France
The George Institute for Global Health Newtown New South Wales Australia
Translational Research Institute Brisbane Australia
University of Manchester Manchester United Kingdom
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011445
- 003
- CZ-PrNML
- 005
- 20210507101546.0
- 007
- ta
- 008
- 210420s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1053/j.ajkd.2020.05.030 $2 doi
- 035 __
- $a (PubMed)32800843
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Htay, Htay $u Department of Renal Medicine, Singapore General Hospital, Singapore
- 245 10
- $a Hemodialysis Use and Practice Patterns: An International Survey Study / $c H. Htay, AK. Bello, A. Levin, M. Lunney, MA. Osman, F. Ye, GE. Ashuntantang, E. Bellorin-Font, MB. Gharbi, SN. Davison, M. Ghnaimat, P. Harden, V. Jha, K. Kalantar-Zadeh, PG. Kerr, S. Klarenbach, CP. Kovesdy, VA. Luyckx, B. Neuen, D. O'Donoghue, S. Ossareh, J. Perl, HU. Rashid, E. Rondeau, EJ. See, S. Saad, L. Sola, I. Tchokhonelidze, V. Tesar, K. Tungsanga, RT. Kazancioglu, A. Yee-Moon Wang, CW. Yang, A. Zemchenkov, MH. Zhao, KJ. Jager, FJ. Caskey, V. Perkovic, KK. Jindal, IG. Okpechi, M. Tonelli, DC. Harris, DW. Johnson
- 520 9_
- $a RATIONALE & OBJECTIVE: Hemodialysis (HD) is the most common form of kidney replacement therapy. This study aimed to examine the use, availability, accessibility, affordability, and quality of HD care worldwide. STUDY DESIGN: A cross-sectional survey. SETTING & PARTICIPANTS: Stakeholders (clinicians, policy makers, and consumer representatives) in 182 countries were convened by the International Society of Nephrology from July to September 2018. OUTCOMES: Use, availability, accessibility, affordability, and quality of HD care. ANALYTICAL APPROACH: Descriptive statistics. RESULTS: Overall, representatives from 160 (88%) countries participated. Median country-specific use of maintenance HD was 298.4 (IQR, 80.5-599.4) per million population (pmp). Global median HD use among incident patients with kidney failure was 98.0 (IQR, 81.5-140.8) pmp and median number of HD centers was 4.5 (IQR, 1.2-9.9) pmp. Adequate HD services (3-4 hours 3 times weekly) were generally available in 27% of low-income countries. Home HD was generally available in 36% of high-income countries. 32% of countries performed monitoring of patient-reported outcomes; 61%, monitoring of small-solute clearance; 60%, monitoring of bone mineral markers; 51%, monitoring of technique survival; and 60%, monitoring of patient survival. At initiation of maintenance dialysis, only 5% of countries used an arteriovenous access in almost all patients. Vascular access education was suboptimal, funding for vascular access procedures was not uniform, and copayments were greater in countries with lower levels of income. Patients in 23% of the low-income countries had to pay >75% of HD costs compared with patients in only 4% of high-income countries. LIMITATIONS: A cross-sectional survey with possibility of response bias, social desirability bias, and limited data collection preventing in-depth analysis. CONCLUSIONS: In summary, findings reveal substantial variations in global HD use, availability, accessibility, quality, and affordability worldwide, with the lowest use evident in low- and lower-middle-income countries.
- 650 _2
- $a arteriovenózní zkrat $7 D001166
- 650 _2
- $a podíl na nákladech $7 D017047
- 650 _2
- $a náklady a analýza nákladů $7 D003365
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a vyspělé země $7 D019049
- 650 _2
- $a rozvojové země $7 D003906
- 650 _2
- $a výdaje na zdravotnictví $7 D005102
- 650 _2
- $a dostupnost zdravotnických služeb $7 D006297
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a internacionalita $7 D038622
- 650 _2
- $a chronické selhání ledvin $x terapie $7 D007676
- 650 _2
- $a nefrologie $7 D009398
- 650 _2
- $a hodnocení výsledků péče pacientem $7 D000071066
- 650 12
- $a lékařská praxe - způsoby provádění $7 D010818
- 650 _2
- $a kvalita zdravotní péče $7 D011787
- 650 12
- $a dialýza ledvin $7 D006435
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a transport pacientů $7 D014187
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bello, Aminu K $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Levin, Adeera $u Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
- 700 1_
- $a Lunney, Meaghan $u Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
- 700 1_
- $a Osman, Mohamed A $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Ye, Feng $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Ashuntantang, Gloria E $u Faculty of Medicine and Biomedical Sciences, Yaounde General Hospital, University of Yaounde I, Yaounde, Cameroon
- 700 1_
- $a Bellorin-Font, Ezequiel $u Division of Nephology and Hypertension, Department of Medicine, Saint Louis University, Saint Louis, MO
- 700 1_
- $a Gharbi, Mohammed Benghanem $u Urinary Tract Diseases Department, Faculty of Medicine and Pharmacy of Casablanca, University Hassan II of Casablanca, Casablanca, Morocco
- 700 1_
- $a Davison, Sara N $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Ghnaimat, Mohammad $u Nephrology Division, Department of Internal Medicine, The Specialty Hospital, Amman, Jordan
- 700 1_
- $a Harden, Paul $u Oxford Kidney Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
- 700 1_
- $a Jha, Vivekanand $u George Institute for Global Health, UNSW, New Delhi; Manipal Academy of Higher Education, Manipal, India; School of Public Health, Imperial College, London, United Kingdom
- 700 1_
- $a Kalantar-Zadeh, Kamyar $u Division of Nephrology and Hypertension and Kidney Transplantation, University of California Irvine Medical Center, Orange, CA
- 700 1_
- $a Kerr, Peter G $u Department of Nephrology, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia; Department of Medicine, Monash University, Clayton, Victoria, Australia
- 700 1_
- $a Klarenbach, Scott $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Kovesdy, Csaba P $u University of Tennessee Health Science Center, Memphis, TN
- 700 1_
- $a Luyckx, Valerie A $u Institute of Biomedical Ethics and the History of Medicine, University of Zurich, Zurich, Switzerland; Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
- 700 1_
- $a Neuen, Brendon $u The George Institute for Global Health, Newtown, New South Wales, Australia
- 700 1_
- $a O'Donoghue, Donal $u Salford Royal NHS Foundation Trust, Salford; University of Manchester, Manchester, United Kingdom
- 700 1_
- $a Ossareh, Shahrzad $u Division of Nephrology, Department of Medicine, Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran
- 700 1_
- $a Perl, Jeffrey $u Division of Nephrology, St. Michael's Hospital and the Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
- 700 1_
- $a Rashid, Harun Ur $u Department of Nephrology, Kidney Foundation Hospital and Research Institute, Dhaka, Bangladesh
- 700 1_
- $a Rondeau, Eric $u Intensive Care Nephrology and Transplantation Department, Hopital Tenon, Assistance Publique-Hopitaux de Paris, Paris, France; Sorbonne Université, Paris, France
- 700 1_
- $a See, Emily J $u Department of Intensive Care, Austin Health, Melbourne, Australia; School of Medicine, University of Melbourne, Melbourne, Australia
- 700 1_
- $a Saad, Syed $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Sola, Laura $u Dialysis Unit, CASMU-IAMPP, Montevideo, Uruguay
- 700 1_
- $a Tchokhonelidze, Irma $u Nephrology Development Clinical Center, Tbilisi State Medical University, Tbilisi, Georgia
- 700 1_
- $a Tesar, Vladimir $u Department of Nephrology, General University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Tungsanga, Kriang $u Department of Medicine, Faculty of Medicine, King Chulalong Memorial Hospital, Chulalongkorn University, Bangkok, Thailand; Bhumirajanagarindra Kidney Institute, Bangkok, Thailand
- 700 1_
- $a Kazancioglu, Rumeyza Turan $u Division of Nephrology, Bezmialem Vakif University, Istanbul, Turkey
- 700 1_
- $a Yee-Moon Wang, Angela $u Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
- 700 1_
- $a Yang, Chih-Wei $u Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan
- 700 1_
- $a Zemchenkov, Alexander $u Department of Internal Disease, Clinical Pharmacology and Nephrology, North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg, Russia; Department of Nephrology and Dialysis, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia
- 700 1_
- $a Zhao, Ming-Hui $u Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China; Key Lab of Renal Disease, Ministry of Health of China, Beijing, China; Key Lab of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, Beijing, China; Peking-Tsinghua Center for Life Sciences, Beijing, China
- 700 1_
- $a Jager, Kitty J $u ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the Netherlands
- 700 1_
- $a Caskey, Fergus J $u Population Health Sciences, University of Bristol, Bristol, United Kingdom; Renal Unit, Southmead Hospital, North Bristol NHS Trust, Bristol, United Kingdom
- 700 1_
- $a Perkovic, Vlado $u The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia
- 700 1_
- $a Jindal, Kailash K $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Okpechi, Ikechi G $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa; Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa
- 700 1_
- $a Tonelli, Marcello $u Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Pan-American Health Organization/World Health Organization's Collaborating Centre in Prevention and Control of Chronic Kidney DiseaseUniversity of Calgary, Calgary, Alberta, Canada
- 700 1_
- $a Harris, David C $u Centre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales
- 700 1_
- $a Johnson, David W $u Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia; Translational Research Institute, Brisbane, Australia; Metro South and Ipswich Nephrology and Transplant Services (MINTS), Princess Alexandra Hospital, Brisbane, Australia. Electronic address: david.johnson2@health.qld.gov.au
- 773 0_
- $w MED00000258 $t American journal of kidney diseases : the official journal of the National Kidney Foundation $x 1523-6838 $g Roč. 77, č. 3 (2021), s. 326-335.e1
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32800843 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507101546 $b ABA008
- 999 __
- $a ok $b bmc $g 1649971 $s 1131824
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 77 $c 3 $d 326-335.e1 $e 20200813 $i 1523-6838 $m American journal of kidney diseases $n Am J Kidney Dis $x MED00000258
- LZP __
- $a Pubmed-20210420
